Connect with us

Technology

University of Maryland, Baltimore and University of Maryland, College Park Announce $10 Million Joint Gift from Edward and Jennifer St. John and the Edward St. John Foundation for New Center for Translational Engineering and Medicine

Published

on

Philanthropic investment to fuel innovation, collaboration and accelerated tech transfer to improve human health in Baltimore and beyond 

COLLEGE PARK, Md., Jan. 10, 2025 /PRNewswire/ — The University of Maryland, Baltimore (UMB) and the University of Maryland, College Park (UMCP) are pleased to announce a $10 million joint gift from Edward and Jennifer St. John and the Edward St. John Foundation. This landmark investment will launch the Edward & Jennifer St. John Center for Translational Engineering and Medicine (CTEM), a collaboration between the University of Maryland School of Medicine (UMSOM) at UMB and the A. James Clark School of Engineering at UMCP. Together, researchers from these distinct disciplines will tackle a broad spectrum of generational health challenges and drive medical innovations that benefit patients in Maryland and beyond. 

Occupying the fourth floor of 4MLK — a new state-of-the-art facility in the University of Maryland BioPark in Baltimore — the Edward & Jennifer St. John Center for Translational Engineering and Medicine will foster face-to-face collaboration among clinicians and engineers as they develop next-generation medical solutions. Their proximity will ensure that the real-world medical needs of healthcare professionals and patients directly inform the development of devices, diagnostics and treatments, and accelerate the pathway from research to patient care. 

“This significant gift allows us to unite the expertise of UMB’s clinicians with the engineering ingenuity of UMCP’s faculty, who together will discover innovative treatments and breakthrough technologies that simply cannot emerge when each works in isolation,” said UMB President Bruce E. Jarrell, MD, FACS. “This synergy opens exciting new possibilities for translating research into tangible solutions that will address today’s most pressing health challenges.”

“This collaboration will be one of the premier partnerships in the country that fully bridges the gap between engineering and medicine to rapidly accelerate solutions on public health, disease and wellness,” said UMCP President Darryll J. Pines, PhD, MS. “Whether it is the invention of new devices and instruments or improved analysis, this center will be leading the way in advancing how clinicians work and how patients heal.” 

Edward St. John graduated from UMCP with an engineering degree and went on to become a noted Baltimore-based business leader and philanthropist. He previously gave $10 million to help build the Edward St. John Learning and Teaching Center, a 187,000-square-foot facility that fosters student-centered learning on the College Park campus. This new gift will establish endowed and current-use professorships in bioengineering, undergraduate and graduate student awards in translational engineering and medicine, and ongoing operating funds for the center.  

He has long championed UMB’s mission to improve the human condition and serve the public good through research, healthcare innovation and education. Building on his early $1 million gift to support the R Adams Cowley Shock Trauma Center and his ongoing commitment to UMB’s CURE Scholars Program, St. John pledged another $1 million in 2021 to establish a Clinical Stem Cell Laboratory at the University of Maryland Medical Center. This newest contribution underscores his and Jennifer St. John’s enduring dedication to improving lives and fueling scientific progress across the state.

“It is our great pleasure to support this transformational, lifesaving and life-altering work, knowing that our contribution helps pave the way for groundbreaking discoveries that will improve and extend lives for years to come,” said Jennifer St. John

“The Edward and Jennifer St. John Center for Translational Engineering and Medicine — where diverse minds unite, each contributing their unique expertise, pushing the boundaries of what’s possible in medicine,” added Edward St. John

Born out of Edward St. John’s commitment to giving back, the Edward St. John Foundation operates on the belief that education has the power to transform lives and provides the foundation for success. Over the years, it has provided financial assistance for educational programs across Maryland and beyond.

Sharon Akers, president of the Edward St. John Foundation, said, “The Edward and Jennifer St. John Center for Translational Engineering and Medicine will provide transformative solutions that will revolutionize healthcare and save lives. It will drive groundbreaking innovation and serve as a platform for recruitment and retention, attracting the best and brightest talent right here to the University of Maryland.”

CTEM is led by Giuliano Scarcelli, PhD, co-director and associate professor in the Fischell Department of Bioengineering in the A. James Clark School of Engineering at UMCP, and Osamah J. Saeedi, MD, clinical co-director and professor of ophthalmology and visual sciences at UMSOM. Their collaborative work using cutting-edge ophthalmologic imaging to address ocular diseases such as glaucoma exemplifies the center’s mission of fostering cross-campus partnerships in the development of interventions that improve patients’ lives.

“Engineers are stewards of technological innovations for the public good, proudly creating and collaborating to improve the human condition. By embedding engineers with doctors, we will improve diagnostics tools, disease treatment and ultimately patient care — helping people live healthier lives,” said Samuel Graham, Jr., PhD, MS, dean of the A. James Clark School of Engineering. “We look forward to the CTEM and its associated educational programs growing the long-standing partnership between the UMSOM and the Clark School’s Fischell Department of Bioengineering, one of the most prestigious bioengineering programs in the country.” 

Scarcelli and Saeedi’s trailblazing research in glaucoma illustrates how the center will cultivate new possibilities across bioengineering and medicine. Building on these breakthroughs, the center will expand into diverse areas of translational science, encouraging broader collaborations that accelerate discovery and improve patient outcomes well beyond eye care. 

 “We are profoundly grateful to Ed and Jennifer St. John for their leadership and commitment to pioneering the next generation of biomedical technology and innovation,” said Mark T. Gladwin, MD, dean of UMSOM. “This new center marks the beginning of a new era in biomedical innovation – a bold vision to break down traditional educational and research silos and create a dynamic ecosystem where engineers and medical professionals work hand-in-hand to solve some of the most pressing health challenges of our time. Imagine a future where biomedical engineers and physician-scientists work together to engineer and rebuild new organs, and use artificial intelligence, wearable devices and robotics to diagnose and treat diseases in the home.”

The 35,000 sq. ft. facility occupies the entire fourth floor of 4MLK and was custom designed by UMSOM to facilitate collaboration between UMB and UMCP researchers. State-of-the-art equipment and easy access to UMB’s core labs and facilities will allow researchers to iterate their ideas as they develop potential new products. 

Its location in 4MLK, the most recent addition to UMB’s 14-acre BioPark, places the center at the heart of a thriving biomedical innovation hub that is transforming Baltimore’s biotechnology landscape. By fostering groundbreaking research and cross-disciplinary collaboration, the center will not only advance medical science but also reinforce the critical role of the biotechnology sector in driving economic growth and scientific progress throughout Baltimore and the greater region. 

“We are thrilled to have the Edward & Jennifer St. John Center for Translational Engineering and Medicine locate in 4MLK,” commented Jim Hughes, chief enterprise and economic development officer and senior vice president at UMB and president of the BioPark. “In addition to providing cutting-edge facilities for life and health science innovation, one of the BioPark’s core missions is to create connection that further strengthens Baltimore’s thriving life science industry. CTEM researchers will join a vibrant, collaborative community in the BioPark and be well-supported as they advance their innovative health care technologies.” 

NOTE TO EDITORS/REPORTERS: Photos, b-roll and additional information will be available here following the ceremony.

ABOUT THE UNIVERSITY OF MARYLAND, BALTIMORE 

The University of Maryland, Baltimore (UMB) was founded in 1807 as the Maryland College of Medicine, which now stands as the nation’s oldest public medical school. In response to growing social and cultural needs, UMB’s mission has evolved and grown tremendously. Widely recognized as a preeminent institution, UMB serves as the academic health, law, and social work university of the University System of Maryland, and is guided by a mission of excellence in education, research, clinical care, and public service. 

UMB is a thriving academic health center combining cutting-edge biomedical research, exceptional patient care, and nationally ranked academic programs. With extramural funding totaling $682 million in Fiscal Year 2021, each tenured/tenure-track faculty member generates an average of $1.5 million in research grants each year. The 3,123 faculty members conduct leading-edge research and develop solutions and technologies that impact human health locally and around the world. World-class facilities and cores, as well as interprofessional centers and institutes, allow faculty to investigate pressing questions in a highly collaborative fashion. As a result, the more than 7,200 students, postdocs, and trainees directly benefit from working and learning alongside leading experts as they push the boundaries of their fields. For a listing of the organized research centers and institutes, visit: https://www.umaryland.edu/research/umb-research-profile/research-centers-and-institutions/ 

ABOUT THE UNIVERSITY OF MARYLAND, COLLEGE PARK 

The University of Maryland (UMD) is the state’s flagship university and a leading public research institution, propelled by a $1.3 billion joint research enterprise. Located four miles from Washington, D.C., the university is dedicated to addressing the grand challenges of our time and is the nation’s first Do Good campus. It is driven by a diverse and proudly inclusive community of more than 50,000 fearless Terrapins. UMD is a top producer of Fulbright scholars and offers an unparalleled student experience with more than 300 academic programs, 25 living-learning programs and 400 study abroad programs. Spurred by a culture of innovation and creativity, UMD faculty are global leaders in their field and include Nobel laureates, Pulitzer Prize winners and members of the national academies. For more information about the University of Maryland, visit umd.edu. 

ABOUT THE EDWARD ST. JOHN FOUNDATION 

The Edward St. John Foundation provides financial assistance to formal educational programs with a primary focus on schools and medical institutions. Over the years, more than $65 million has been contributed, pledged and gifted through donations by the Foundation, Edward St. John and St. John Properties to more than 750 organizations. The Foundation is funded through 7.5% of the annual net income of St. John Properties. The mission is based on the belief that the transformative powers of education can change lives and strengthen communities. 

View original content to download multimedia:https://www.prnewswire.com/news-releases/university-of-maryland-baltimore-and-university-of-maryland-college-park-announce-10-million-joint-gift-from-edward-and-jennifer-st-john-and-the-edward-st-john-foundation-for-new-center-for-translational-engineering-and-medic-302348091.html

SOURCE University of Maryland

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

Boqii Announces ADS Ratio Change

Published

on

By

SHANGHAI, Jan. 10, 2025 /PRNewswire/ — Boqii Holding Limited (“Boqii” or the “Company”) (NYSE American: BQ) today announced that it will change its ratio of its American Depositary Shares (“ADSs”) to Class A ordinary shares from one (1) ADS representing fifteen (15) Class A ordinary shares to one ADS representing one hundred and fifty (150) Class A ordinary shares (the “ADS Ratio Change”). The ADS Ratio Change is expected to become effective on or about January 21, 2025 (U.S. Eastern Time) (the “ADS Ratio Change Effective Date”).

For Boqii’s ADS holders, the ADS Ratio Change will have the same effect as a 1-for-10 reverse split on the existing ADSs. Each ADS holder on the ADS Ratio Change Effective Date will be required on mandatory basis to surrender to The Bank of New York Mellon, as depositary, (the “Depositary”) for Boqii’s ADS program, every 10 old ADSs held in exchange for one new ADSs. No action is required by holders of uncertificated ADSs to effect the ADS Ratio Change as the change will be effected on the books of the Depositary.  

No fractional new ADSs will be issued in connection with the ADS Ratio Change. Instead, the Depositary will attempt to sell any fractional entitlements to new ADSs and the net cash proceeds from the sale of the fractional ADS entitlements (after deduction of fees, taxes and expenses) will be distributed to the applicable ADS holders by the Depositary. Boqii’s ADSs will continue to be traded on the NYSE American under the ticker symbol “BQ”. As a result of the ADS Ratio Change, the ADS price is expected to increase proportionally, although the Company can give no assurance that the ADS price after the ADS Ratio Change will be equal to or greater than ten (10) times the ADS price before the change.

 About Boqii Holding Limited 

Boqii Holding Limited (NYSE American: BQ) is a leading pet-focused platform in China. It is the leading online destination for pet products and supplies in China with a broad selection of high-quality products including global leading brands, local emerging brands, and its own private label, Yoken, Mocare and D-cat, offered at competitive prices. Boqii’s online sales platforms, including Boqii Mall and our flagship stores on third-party e- commerce platforms, provide customers with convenient access to a wide selection of high-quality pet products and an engaging and personalized shopping experience. Its Boqii Community provides an informative and interactive content platform for users to share their knowledge and love for pets.

Safe Harbor Statement 

This press release contains forward-looking statements. These statements are made under the “safe harbor” provisions of the U.S. Private Securities Litigation Reform Act of 1995. Statements that are not historical facts, including statements about the Company’s beliefs and expectations, are forward-looking statements. Forward-looking statements involve inherent risks and uncertainties, and a number of factors could cause actual results to differ materially from those contained in any forward-looking statement. In some cases, forward-looking statements can be identified by words or phrases such as “may,” “will,” “expect,” “anticipate,” “target,” “aim,” “estimate,” “intend,” “plan,” “believe,” “potential,” “continue,” “is/are likely to” or other similar expressions. The Company may also make written or oral forward-looking statements in its reports filed with, or furnished to, the U.S. Securities and Exchange Commission (“SEC”), in its annual reports to shareholders, in press releases and other written materials and in oral statements made by its officers, directors or employees to third parties. Further information regarding such risks, uncertainties or factors is included in the Company’s filings with the SEC. All information provided in this press release is as of the date of this press release, and the Company does not undertake any duty to update such information, except as required under applicable law.

For investor inquiries, please contact: 

Boqii Holding Limited
Investor Relations
Tel: +86-21-6882-6051
Email: ir@boqii.com 

View original content:https://www.prnewswire.com/news-releases/boqii-announces-ads-ratio-change-302348055.html

SOURCE Boqii Holding Limited

Continue Reading

Technology

NASA Awards 2025 Innovative Technology Concept Studies

Published

on

By

WASHINGTON, Jan. 10, 2025 /PRNewswire/ — NASA selected 15 visionary ideas for its NIAC (NASA Innovative Advanced Concepts) program which develops concepts to transform future missions for the benefit of all. Chosen from companies and institutions across the United States, the 2025 Phase I awardees represent a wide range of aerospace concepts.

The NIAC program nurtures innovation by funding early-stage technology concept studies for future consideration and potential commercialization. The combined award for the 2025 concepts is a maximum of $2.625M in grants to evaluate technologies that could enable future aerospace missions.

“Our next steps and giant leaps rely on innovation, and the concepts born from NIAC can radically change how we explore deep space, work in low Earth orbit, and protect our home planet” said Clayton Turner, associate administrator for NASA’s Space Technology Mission Directorate in Washington. “From developing small robots that could swim through the oceans of other worlds to growing space habitats from fungi, this program continues to change the possible.”

The newly selected concepts include feasibility studies to explore the Sun’s influence on our solar system, build sustainable lunar habitats from glass, explore Saturn’s icy moon, and more. All NIAC studies are in the early stages of conceptual development and are not considered official NASA missions.

Ryan Weed, Helicity Space LLC in Pasadena, California, proposes a constellation of spacecraft powered by the Helicity Drive, a compact and scalable fusion propulsion system, that could enable rapid, multi-directional exploration of the heliosphere and beyond, providing unprecedented insights on how the Sun interacts with our solar system and interstellar space. Demonstrating the feasibility of fusion propulsion could also benefit deep space exploration including crewed missions to Mars.

Martin Bermudez, Skyeports LLC in Sacramento, California, presents the concept of constructing a large-scale, lunar glass habitat in a low-gravity environment. Nicknamed LUNGS (Lunar Glass Structure), this approach involves melting lunar glass compounds to create a large spherical shell structure. This idea offers a promising solution for establishing self-sustaining, large-scale habitats on the lunar surface.

Justin Yim, University of Illinois in Urbana, proposes a jumping robot appropriately named LEAP (Legged Exploration Across the Plume), as a novel robotic sampling concept to explore Enceladus, a small, icy moon of Saturn that’s covered in geysers, or jets. The LEAP robots could enable collection of pristine, ocean-derived material directly from Enceladus’s jets and measurement of particle properties across multiple jets by traveling from one to another.

“All advancements begin as an idea. The NIAC program allows NASA to invest in unique ideas enabling innovation and supporting the nation’s aerospace economy,” said John Nelson, program executive for NASA’s Innovative Advanced Concepts in Washington.

The NIAC researchers, known as fellows, will investigate the fundamental premise of their concepts, identify potential challenges, and look for opportunities to bring these concepts to life.

In addition to the projects mentioned above, the following selectees received 2025 NIAC Phase I grants:

Michael Hecht, Massachusetts Institute of Technology, Cambridge: EVE (Exploring Venus with Electrolysis)Selim Shahriar, Northwestern University, Evanston, Illinois: SUPREME-QG: Space-borne Ultra-Precise Measurement of the Equivalence Principle Signature of Quantum GravityPhillip Ansell, University of Illinois, Urbana: Hy2PASS (Hydrogen Hybrid Power for Aviation Sustainable Systems)Ryan Benson, ThinkOrbital Inc., Boulder, Colorado: Construction Assembly DestinationGyula Greschik, Tentguild Engineering Co, Boulder, Colorado: The Ribbon: Structure Free Sail for Solar Polar ObservationMarco Quadrelli, NASA’s Jet Propulsion Laboratory in Southern California: PULSAR: Planetary pULSe-tAkeRBen Hockman, NASA’s Jet Propulsion Laboratory in Southern California: TOBIAS: Tethered Observatory for Balloon-based Imaging and Atmospheric SamplingKimberly Weaver, NASA’s Goddard Space Flight Center in Greenbelt, Maryland: Beholding Black Hole Power with the Accretion Explorer InterferometerJohn Mather NASA’s Goddard Space Flight Center in Greenbelt, Maryland: Inflatable Starshade for Earthlike ExoplanetsRobert Hinshaw, NASA’s Ames Research Center in California’s Silicon Valley: MitoMars: Targeted Mitochondria Replacement Therapy to Boost Deep Space EnduranceChristine Gregg, NASA’s Ames Research Center in California’s Silicon Valley: Dynamically Stable Large Space Structures via Architected MetamaterialsSaurabh Vilekar, Precision Combustion, North Haven, Connecticut: Thermo-Photo-Catalysis of Water for Crewed Mars Transit Spacecraft Oxygen Supply

NASA’s Space Technology Mission Directorate funds the NIAC program, as it is responsible for developing the agency’s new cross-cutting technologies and capabilities to achieve its current and future missions.

To learn more about NIAC, visit:

https://www.nasa.gov/niac

View original content to download multimedia:https://www.prnewswire.com/news-releases/nasa-awards-2025-innovative-technology-concept-studies-302348385.html

SOURCE NASA

Continue Reading

Technology

Corn Next Launches CornNext-17: A Groundbreaking Sustainable Solution to Plastic Pollution

Published

on

By

IRVINE, Calif., Jan. 11, 2025 /PRNewswire/ — Corn Next, a leader in sustainable innovation and biodegradable solutions, has officially launched CornNext-17, a game-changing bio-based material designed to combat the global plastic pollution crisis. Accompanying this launch is the release of the CornNext-17 White Paper, a detailed report that highlights the revolutionary features of CornNext-17, its potential to replace traditional plastics, and its critical role in supporting global sustainability initiatives.

Derived from renewable corn starch, CornNext-17 utilizes a patented fermentation-based process to create a fully biodegradable material with superior versatility and performance. Unlike traditional plastics and bio-plastics such as PLA and PHA, CornNext-17 retains its natural polysaccharide structure, enabling rapid decomposition within 30 days in natural environments while maintaining the mechanical properties necessary for diverse applications.

“CornNext-17 represents a significant leap forward in sustainable materials,” said Randy Yongzhong Zhang, Founder and CEO of Corn Next. “We are proud to offer a solution that addresses the urgent need for environmentally friendly alternatives to conventional plastics. The development of CornNext-17 is guided by our vision to revolutionize how materials are used and discarded. As a fully natural biodegradable innovation, it marks not just a breakthrough in material science, but a significant milestone in humanity’s pursuit of a greener, more sustainable future.”

Key Features of CornNext-17

Fully Biodegradable: Decomposes naturally within 30 days, leaving no harmful residues.Versatile: Suitable for a wide range of applications, including packaging, consumer goods, and industrial components.Cost-Effective: Produced through an efficient manufacturing process, offering competitive pricing.High Performance: Exhibits excellent mechanical properties, including strength, flexibility, and heat resistance.Eco-Friendly: Derived from renewable corn starch and produced without harmful chemicals.

Market Potential and Industrial Applications

CornNext-17 has the potential to transform multiple industries by replacing traditional plastics with a sustainable alternative:

Consumer Goods: CornNext-17 is ideal for creating compostable tableware, single-use products, food containers, and eco-friendly packaging solutions that cater to environmentally conscious consumers.Packaging Industry: The material’s strength, flexibility, and resistance to heat and moisture make it a superior choice for biodegradable packaging, including retail, food, and industrial applications.Agriculture: CornNext-17 can be used to manufacture biodegradable mulch films, seedling trays, and irrigation components, reducing waste and enhancing soil health.Medical and Healthcare: With its ability to decompose fully, CornNext-17 is well-suited for disposable medical supplies such as gloves, syringes, and packaging, ensuring environmental safety.Automotive: Lightweight and durable, CornNext-17 can be utilized in creating automotive components such as panels, trim, and interior parts, contributing to vehicle sustainability and fuel efficiency.Electronics: As a biodegradable alternative, CornNext-17 can replace certain plastic components in electronics, helping reduce electronic waste.

The global push for environmentally sustainable materials positions CornNext-17 to capitalize on increasing regulatory support and consumer demand for green products. Its adaptability, cost-effectiveness, and eco-friendly properties provide a competitive edge in addressing the growing plastic pollution crisis.

Why CornNext-17 Matters

Plastic waste remains one of the most pressing environmental challenges, with over 400 million tons of plastic produced annually and only a fraction recycled. CornNext-17’s innovative composition and rapid biodegradability make it a transformative solution for reducing reliance on petrochemical-based plastics and mitigating environmental harm.

Looking for Partnership

Corn Next is committed to advancing CornNext-17’s applications through ongoing research and development, fostering innovation in biodegradable materials. The company seeks strategic collaborations with industry leaders, partners, investors, financial institutions, government agencies, and research organizations to drive the widespread adoption of CornNext-17 and accelerate the global shift toward a more sustainable future.

Download the White Paper

Detailed information on the potential of this revolutionary material can be downloaded from Corn Next’s website at https://www.cornnext.com/CornNext-17 by clicking “Learn More.”

About Corn Next

Corn Next (or Y & J World Inc.) is a pioneering biotech company based in Irvine, California, dedicated to eliminating plastic pollution. We specialize in developing bio-based new materials such as CornNext-17, a patented, 100% natural, biodegradable material derived from renewable corn starch. Unlike traditional plastics, CornNext-17 fully decomposes within 30 days without leaving toxins or requiring costly recycling. After eight years of R&D, we transformed CornNext-17 into a granular form, securing our proprietary technology and expanding its applications. This innovation led to the world’s first corn-based drinking straw, protein spoon, dinner knife, and forks, with future uses in utensils, dental floss, packaging and more. Corn Next is committed to replacing single-use and durable plastics with sustainable, plastic-free alternatives—free from plastics, PHA, PLA, and other bio-plastics. Our mission is to drive a cleaner, greener future. For more information, please visit https://www.cornnext.com/

Contact: David Xu, Email: david.x@cornnext.com

SOURCE Corn Next Inc.

Continue Reading

Trending